Compare FLO & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLO | BHC |
|---|---|---|
| Founded | 1919 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2000 | 1996 |
| Metric | FLO | BHC |
|---|---|---|
| Price | $8.65 | $5.66 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $11.20 | $8.00 |
| AVG Volume (30 Days) | ★ 4.2M | 1.6M |
| Earning Date | 05-15-2026 | 04-29-2026 |
| Dividend Yield | ★ 11.16% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 0.40 | N/A |
| Revenue | $5,256,479,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | $0.65 | N/A |
| P/E Ratio | $21.06 | ★ N/A |
| Revenue Growth | ★ 3.00 | N/A |
| 52 Week Low | $7.86 | $4.41 |
| 52 Week High | $17.68 | $8.69 |
| Indicator | FLO | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 52.24 |
| Support Level | $7.86 | $5.52 |
| Resistance Level | $9.03 | $5.97 |
| Average True Range (ATR) | 0.30 | 0.23 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 47.21 | 29.12 |
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.